Lilly JVBA
A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab vs Docetaxel and Placebo in Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy.
A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab vs Docetaxel and Placebo in Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy.